Tax
Tax Reconciliation: Other Adjustments
Vertex Pharmaceuticals Tax Reconciliation: Other Adjustments remained flat by 0.0% to $0.07 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 2436.4%, from $0.00 to $0.07. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2024Feb 13, 2026
How to read this metric
An increase may indicate rising complexity in tax planning or non-recurring tax adjustments, while a decrease suggests greater tax predictability.
Detailed definition
Represents the residual, miscellaneous adjustments that impact the effective tax rate reconciliation but do not fall int...
Peer comparison
Commonly found in tax footnotes as 'other' or 'miscellaneous' items in the effective tax rate reconciliation table of peer companies.
Metric ID:
cat_tax_reconciliation_other_adjustmentsHistorical Data
2 years
| FY'23 | FY'24 | |
|---|---|---|
| Value | $0.01 | $0.28 |
| YoY Change | — | >999% |
Range$0.01 – $0.28
Avg YoY Growth>999%
Median YoY Growth>999%
Tax Reconciliation: Other Adjustments at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's tax reconciliation: other adjustments?
- Vertex Pharmaceuticals (VRTX) reported tax reconciliation: other adjustments of $0.07 in Q4 2024.
- How has Vertex Pharmaceuticals's tax reconciliation: other adjustments changed year-over-year?
- Vertex Pharmaceuticals's tax reconciliation: other adjustments increased by 2436.4% year-over-year, from $0.00 to $0.07.
- What does tax reconciliation: other adjustments mean?
- Miscellaneous adjustments that impact the company's effective tax rate.